Ghana targets first locally manufactured vaccine by 2027

Partnership drives vaccine production The CEO said the project was being implemented through a partnership involving the National Vaccine Institute, Atlantic Lifesciences Limited, the Noguchi Memorial Institute for Medical Research and PT Bio Farma of Indonesia.

He explained that the National Vaccine Institute had assembled a team of experts from Ghana, including officials from the Food and Drugs Authority (FDA) and private manufacturers, who travelled to Indonesia to facilitate the technology transfer required for local production.

The initiative forms part of broader efforts to establish a sustainable vaccine manufacturing ecosystem in Ghana, including developing technical expertise, strengthening regulatory capacity and building local production capabilities.